Biohaven Stock Down Fund's Turnaround Bet Sparks Hope
A patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
Find out how to use credit cards smartly for cash back rewards and increase your financial benefits. Start optimizing today!
22,942 articlesA patient biotech story gets a glimmer of hope as One Fund reveals a new $6 million stake in Biohaven. Here’s what th...
When Road releases its Q2 results, the transcript hides clues about growth and risk. This guide translates the road 2...
Keysight's Q2 2026 earnings transcript sheds light on demand, margins, and strategic priorities. This guide decodes t...
Investors are weighing Credo Technology Group after its latest earnings report. This article breaks down what the res...
A surprising rally in small-cap value equities challenges the usual price-pressures from inflation and higher rates. ...
Two consumer stars with very different paths battle for investors' attention. One mixes health-forward fast-casual ex...
As AI demand accelerates, investors wonder if Micron Technology can become Nvidia. This practical guide breaks down t...
A potential federal shift on cannabis could redefine the playing field for Canopy Growth, Tilray, and Green Thumb. Th...
Five stalwart Dividend Aristocrats continue to anchor retirement portfolios with rising payouts, steady cash flow, an...
Polestar stock plunged 29% in a single week. There was no obvious single news trigger, but a mix of market forces and...
Rocket Lab and AST SpaceMobile pursue different spacefrontiers, from reliable launches to space-based connectivity. T...
U.S. investors are watching three dividend aristocrats abroad as currency moves and energy swings threaten steady inc...